Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am Surg ; 88(7): 1626-1630, 2022 Jul.
Article in English | MEDLINE | ID: mdl-33629876

ABSTRACT

Many students, residents, and learners have heard of the infamous bank robber, who when arrested was asked "Why do you rob banks?" He supposedly replied "Because that's where the money is." Except it did not happen that way. He did rob close to a hundred banks and jewelry stores and stole an estimated $2,000,000.1 A well-known maxim in medicine and surgery, few know the details of the unrelated men behind "Sutton's Law."

2.
J Trauma ; 58(6): 1167-70, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15995464

ABSTRACT

BACKGROUND: Low-molecular-weight heparin is effective for prevention of venous thromboembolism. The efficacy of daily dosing in critically ill patients is unknown. METHODS: Seventeen critically ill patients on 40 mg of enoxaparin subcutaneously daily were studied. Anti-Xa activity was measured 4 hours after the third dose and before the fourth dose. Adverse events were recorded. RESULTS: Mean peak anti-Xa activity was 0.19 +/- 0.09 International Units/mL and mean trough was 0.044 +/- 0.04 International Units/mL. The recommended target range is 0.1 to 0.2 International Units/mL. The trough was below therapeutic levels in all but two patients. One thrombosis occurred in a patient despite a therapeutic trough. CONCLUSION: Daily dosing of enoxaparin is inadequate for critically ill patients and should be abandoned. Further studies using twice daily dosing are needed. Patients with renal insufficiency may require an increased interval of administration (daily dosing). Anti-Xa levels may not correlate with the risk of thromboembolic complications. Patients with renal insufficiency and morbid obesity may require alternative dosing and monitoring of anti-Xa levels.


Subject(s)
Anticoagulants/administration & dosage , Critical Illness/therapy , Enoxaparin/administration & dosage , Factor Xa Inhibitors , Fibrinolytic Agents/administration & dosage , Pulmonary Embolism/prevention & control , Venous Thrombosis/prevention & control , Wounds, Nonpenetrating/therapy , Anticoagulants/pharmacokinetics , Enoxaparin/pharmacokinetics , Fibrinolytic Agents/pharmacokinetics , Humans , Prospective Studies
3.
J Trauma ; 57(6): 1178-83, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15625447

ABSTRACT

BACKGROUND: This study is aimed at evaluating the safety and efficacy of intrapleural tissue plasminogen activator (TPA) for complicated pleural effusions, including posttraumatic hemothorax. METHODS: Data were retrospectively collected from hospitalized patients over a 4-year period (1999-2003) who were treated with intrapleural TPA after failing drainage by tube thoracostomy. Pre- and post-TPA imaging studies were reviewed and scored by a blinded radiologist. RESULTS: Forty-one consecutive patients with 42 effusions were identified with the following indications: 6 traumatic hemothoraces (14%), 22 loculated pleural effusions (52%), 2 line-associated hemothoraces (5%), and 12 empyemas (29%). Nine patients (22%) required operative drainage including two with posttraumatic hemothoraces. All patients managed nonoperatively demonstrated radiographic improvement after TPA administration. One patient (2.4%) developed hematuria, requiring transfusion. No trauma patient required TPA-related blood transfusion and no deaths were attributable to TPA therapy. CONCLUSION: Intrapleural TPA administration appears safe for use in complicated pleural effusions and may decrease the need for operative intervention.


Subject(s)
Fibrinolytic Agents/therapeutic use , Pleural Effusion/drug therapy , Tissue Plasminogen Activator/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Analysis of Variance , Comorbidity , Empyema, Pleural/drug therapy , Empyema, Pleural/etiology , Female , Fibrinolytic Agents/administration & dosage , Humans , Infusions, Parenteral , Male , Middle Aged , Pleural Effusion/complications , Pleural Effusion/epidemiology , Pneumothorax/drug therapy , Pneumothorax/etiology , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Retrospective Studies , Tissue Plasminogen Activator/administration & dosage , Treatment Outcome
4.
Am Surg ; 68(6): 590-3, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12079145

ABSTRACT

Percutaneous endoscopic gastrostomy (PEG) is well established as a safe and effective means of providing enteral feeding access in patients unable to tolerate oral feeding. There is some question, however, as to the true incidence of free air after PEG and the clinical significance of free air in these patients. We report our experience with 119 patients over 4 years who underwent placement of a percutaneous gastrostomy tube. This study is a retrospective review of percutaneous endoscopic gastrostomies performed by the Critical Care Service for Surgery (CCSS). A database of percutaneous endoscopic gastrostomies performed by the CCSS was maintained from September 1997 through December 2001. Complications of percutaneous gastrostomies were added to the database when noted. The electronic medical record of all patients was reviewed for the results of radiographic studies. Prior abdominal operations were noted as well as gastrostomy tube complications and outcome. A total of 115 intensive care unit patients underwent PEG placement by the CCSS. This total includes 18 patients who had undergone prior upper abdominal surgery, Three additional patients who underwent placement of a gastrostomy tube by vascular interventional radiology and one patient who underwent PEG placement by the ear, nose, and throat service were brought to the attention of CCSS secondary to complications for a total of 119 patients. Only four patients (3.4%) were found to have free air on subsequent chest radiograph. Six patients (5.2%) were found to have free air on abdominal CT scans. Two patients with free air on CT underwent exploratory celiotomy as a result of additional signs of peritonitis. Both were negative explorations. The incidence of free air after PEG in our experience is significantly less than the incidence in previous studies. In patients with free air after PEG placement exploratory celiotomy is not indicated in the absence of other clinical findings of peritonitis. Additionally it was noted that PEG placement could safely be performed in patients with prior upper abdominal surgery with a low incidence of complications.


Subject(s)
Gastrostomy/adverse effects , Gastrostomy/methods , Pneumoperitoneum/etiology , Endoscopy/adverse effects , Endoscopy/methods , Humans , Incidence , Middle Aged , Pneumoperitoneum/diagnostic imaging , Pneumoperitoneum/epidemiology , Retrospective Studies , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...